SCHEMBL3028816

SCHEMBL3028816

COc1ccc(CCNC(=O)c2ccc3cc(C(=O)NO)ccc3c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.63
MAPT P10636 3/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
NPC1 O15118 1/20 0.63
LMNA P02545 1/20 0.60
KMT2A Q03164 4/20 0.59
MEN1 O00255 3/20 0.59
HDAC8 Q9BY41 4/20 0.58
HDAC6 Q9UBN7 4/20 0.58
HDAC11 Q96DB2 3/20 0.58
HDAC1 Q13547 3/20 0.58
HDAC2 Q92769 3/20 0.57
HDAC3 O15379 2/20 0.57
HDAC4 P56524 2/20 0.57
HDAC7 Q8WUI4 2/20 0.57
HDAC10 Q969S8 2/20 0.57
HDAC9 Q9UKV0 2/20 0.57
HDAC5 Q9UQL6 2/20 0.57
NCOR2 Q9Y618 1/20 0.57
CA1 P00915 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3035750 0.97 MAPT (0.61) RAB9AMAPTSMN1; SMN2NPC1LMNA
SCHEMBL6570625 0.92 RAB9A (0.70) RAB9AMAPTSMN1; SMN2NPC1LMNA
SCHEMBL3032563 0.90 NAMPT (0.55) RAB9AMAPTSMN1; SMN2NPC1HDAC8
SCHEMBL3031951 0.88 RAB9A (0.65) RAB9AMAPTSMN1; SMN2NPC1LMNA
SCHEMBL3035635 0.86 HDAC2 (0.62) RAB9AMAPTSMN1; SMN2NPC1LMNA
SCHEMBL15618832 0.86 RAB9A (0.77) RAB9AMAPTSMN1; SMN2NPC1LMNA
SCHEMBL3037525 0.85 HDAC6 (0.60) RAB9ANPC1HDAC8HDAC6HDAC11
SCHEMBL5943749 0.85 SMN1; SMN2 (0.61) RAB9AMAPTSMN1; SMN2NPC1LMNA
SCHEMBL3029153 0.84 HDAC1 (0.71) RAB9ASMN1; SMN2NPC1KMT2AMEN1
SCHEMBL3034726 0.84 GAA (0.56) RAB9AMAPTNPC1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 RAB9A 4531/4885MAPT 974/4885SMN1; SMN2 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.